Skip to main content
Back
SMSZF logo

SMS Co., Ltd.

Data quality: 100%
Overbought
SMSZF
OTC Healthcare Medical - Healthcare Information Services
$8.56
$0.00 (0.00%)
Mkt Cap: 702.61M
Day Range
$8.56 $10.31
52-Week Range
$6.91 $17.86
Volume
100
50D / 200D Avg
$8.56 / $8.56
Prev Close
$8.56

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (627 peers)

Metric Stock Sector Median
P/E 0.1 0.3
P/B 0.0 2.9
ROE % 13.2 3.7
Net Margin % 9.9 3.8
Rev Growth 5Y % 14.1 10.0
D/E 0.2 0.2

Analyst Price Target

No analyst coverage available

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2030 $1.00
$0.98 – $1.01
 90 B 1
FY2029 $0.88
$0.86 – $0.89
 83 B 1
FY2028 $0.65
$0.64 – $0.66
 77 B 1

Key Takeaways

Revenue grew 14.10% annually over 5 years — strong growth
Earnings declined -16.23% over the past year
ROE of 13.22% — decent returns on equity
Debt/Equity of 0.17 — conservative balance sheet
Generating 1.74B in free cash flow
P/E of 0.12 — trading at a low valuation

Growth

Revenue Growth (5Y)
14.10%
Revenue (1Y)12.93%
Earnings (1Y)-16.23%
FCF Growth (3Y)542.14%

Quality

Return on Equity
13.22%
ROIC8.58%
Net Margin9.93%
Op. Margin10.39%

Safety

Debt / Equity
0.17
Current Ratio1.61
Interest Coverage62.72

Valuation

P/E Ratio
0.12
P/B Ratio0.01
EV/EBITDA-1.17
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 12.93% Revenue Growth (3Y) 1231.62%
Earnings Growth (1Y) -16.23% Earnings Growth (3Y) -2.79%
Revenue Growth (5Y) 14.10% Earnings Growth (5Y) 5.97%
Profitability
Revenue (TTM) 60.95B Net Income (TTM) 6.05B
ROE 13.22% ROA 7.91%
Gross Margin 88.35% Operating Margin 10.39%
Net Margin 9.93% Free Cash Flow (TTM) 1.74B
ROIC 8.58% FCF Growth (3Y) 542.14%
Safety
Debt / Equity 0.17 Current Ratio 1.61
Interest Coverage 62.72 Dividend Yield 0.01%
Valuation
P/E Ratio 0.12 P/B Ratio 0.01
P/S Ratio 0.01 PEG Ratio -2.65
EV/EBITDA -1.17 Dividend Yield 0.01%
Market Cap 702.61M Enterprise Value -7.42B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 60.95B 53.97B 343.74M 38.90B 35.96B
Net Income 6.05B 7.23B 6.41B 5.41B 4.80B
EPS (Diluted) 70.95 82.74 73.13 61.77 54.86
Gross Profit 53.85B 47.54B 280.04M 262.57M 269.85M
Operating Income 6.34B 8.27B 7.28B 6.32B 5.47B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 76.54B 72.48B 490.12M 464.94M 447.46M
Total Liabilities 29.22B 28.19B 200.91M 218.55M 242.37M
Shareholders' Equity 47.32B 44.28B 38.42B 29.99B 22.66B
Total Debt 8.05B 6.43B 8.33B 10.37B 13.52B
Cash & Equivalents 16.18B 18.24B 121.71M 116.05M 91.80M
Current Assets 38.66B 37.78B 32.55B 27.82B 23.22B
Current Liabilities 23.99B 21.33B 18.02B 16.21B 13.88B

Strategy Scores

This stock passed the criteria for 3 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#552 of 827
35
Growth Price/Sales Ratio Focus (Ken Fisher)
#270 of 618
39
Value Defensive Investing (Benjamin Graham)
#415 of 709
24

Recent Activity

Entered Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entered Defensive Investing (Benjamin Graham)
Mar 24, 2026